Company: ACHV
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-036831
Chunk: 7

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 15
Chunk 7
---
      
    S-4/A
      
    333-216961
      
    10.24
      
    May 3, 2017

    10.24
      
    Technical and Quality Agreement, by and between Sopharma AD and Extab Corporation, dated May 14, 2015*
      
    S-4/A
      
    333-216961
      
    10.25
      
    May 3, 2017

    10.25
     
    Share Purchase Agreement, by and between Sopharma AD and Achieve Life Sciences, Inc., dated May 14, 2015*
     
    10-K
     
    033-80623
     
    10.21
     
    March 28, 2024

    10.26
      
    License of Technology, by and between University of Bristol and Achieve Life Science, Inc., dated July 13, 2016*
      
    S-4/A
      
    333-216961
      
    10.27
      
    May 3, 2017

    10.27
      
    Amendment One to License of Technology, dated January 22, 2018, by and between Achieve Life Science, Inc., and the University of Bristol*
      
    10-Q/A
      
    033-80623
      
    10.1
      
    May 23, 2018

    10.28
      
    Amended and Restated Commercial Agreement on Supply of Pharmaceutical Products, dated July 28, 2017, by and 
      
    10-Q
      
    033-80623
      
    10.1
      
    November 9, 2017

100

    ExhibitNumber
      
    Description
      
    Incorporated by Reference
      
    Filed/FurnishedHerewith

    Form
      
    File No.
      
    Exhibit
      
    Filing Date

    between Achieve Life Science, Inc., and Sopharma AD*

    10.29
     
    Letter of Variation, dated September 28, 2020, by and between Achieve Pharma UK Limited and Richard Stewart††
     
    10-Q
     
    033-80623
     
    10.1
     
    November 12, 2020

    10.30
     
    Contingent Convertible Debt Agreement, dated July 25, 2024, between Achieve Life Sciences, Inc., and Silicon Valley Bank